PERUBAHAN KADAR NT-proBNP PASCA TERAPI KOMBINASI β-BLOKER

DAN ACE-INHIBITOR PADA PASIEN GAGAL JANTUNG (Penelitian dilaksanakan di Poli Jantung RSUD Dr. Soetomo Surabaya) by REINE RISA RISTHANTI, 051315153010
viii
ABSTRACT
NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH β-
BLOCKER AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE
Reine Risa Risthanti
Background : Heart failure (HF) is the final common stage of many diseases of the heart. NT-
proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of
HF. The prognostic power of NT-proBNP is well established in heart failure patients. Higher
concentrations of NT-proBNP are associated with increased cardiovascular events and all cause
mortality. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP level
in patient with HF. The use of Bisoprolol as a combination with ACE-inhibitor is still dominate
in outpatient setting at Dr. Soetomo teaching hospital.
Objective : The objective of this study is to analyze NT-proBNP level changes as an indicator in
cardiac function after combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.
Methods : This study was prospective, observational and conducted in outpatient setting.
Consecutive patients who meet the inclusion criteria of the study were included. Blood samples
were taken at pre and 2 months post combination therapy with Bisoprolol and ACE-inhibitor,
then NT-proBNP level was measured with IMMULITE®. Ethical clearance of this study was
held at Dr. Soetomo Teaching Hospital.
Result : There were 14 patients enrolled in this study (7 males, 7 females). The result showed
that NT-proBNP 2 months post combination therapy with Bisoprolol and ACE-inhibitor is
significantly decreased than baseline with mean baseline of NT-proBNP level is 4191.43 ±
4367.277 pg/ml to 2786.79 ± 2485.199 pg/ml (p=0.025). NT-proBNP levels decrease by 20%-80%
of baseline or below the cutpoint <1000 pg/ml in outpatient setting can reduce the risk of death,
transplantation, and the incidence of hospital admission. From a total 14 patients, 9 patients had
NT-proBNP decreases >20% (20.1% – 56.4%) and 3 patients had NT-proBNP decreases <20%
(1.8%; 6.6%; and 12.4%). There were 2 patients with NT-proBNP increases >40% (43.4% and
40.4%).
Conclusion : There was a significant decreases in NT-proBNP level after 2 months combination
therapy with Bisoprolol and ACE-inhibitor in patient with HF.
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